Activation of G proteins by neuropeptide Y and γ-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1250-1256

  Odagaki, Yuji ^a   Nishi, Nobuyuki ^a   Nakagawa, Shin ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ARTICLE; BRAIN MEMBRANE; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION;

ANIMALS; ARGININE; BIOTRANSFORMATION; CELL MEMBRANE; CEREBRAL CORTEX; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; MAGNESIUM CHLORIDE; MALE; NEUROPEPTIDE Y; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, NEUROPEPTIDE Y; STIMULATION, CHEMICAL;

EID: 0032724697     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Balasubramaniam A (1997) Neuropeptide Y family of hormones: Receptor subtypes and antagonists. Peptides 18:445-457.
2. Chance WT, Sheriff S, Foley-Nelson T, Fischer JE and Balasubramaniam A (1989) Pertussis toxin inhibits neuropeptide Y-induced feeding in rats. Peptides 10:1283-1286.
3. 2 radioligands. J Pharmacol Exp Ther 272:673-680.
4. 2 receptor radioligands. Synapse 22:139-158.
5. Emadi-Khiav B, Mousli M, Bronner C and Landry Y (1995) Human and rat cutaneous mast cells: Involvement of a G protein in the response to peptidergic stimuli. Eur J Pharmacol 272:97-102.
6. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysae P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA and Weinshank RL (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (Lond) 382:168-171.
7. Grundemar L and Hakanson R (1991) Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells. Br J Pharmacol 104:776-778.
8. Grundemar L, Krstenansky JL and Hakanson R (1994) Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells: A direct effect on G proteins? Eur J Pharmacol 258:163-166.
9. Harfstrand A, Fredholm B and Fuxe K (1987) Inhibitory effects of neuropeptide Y on cyclic AMP accumulation in slices of the nucleus tractus solitarius region of the rat. Neurosci Lett 76:185-190.
10. Higashijima T, Uzu S, Nakajima T and Ross EM (1988) Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem 263:6491-6494.
11. Karelson E, Laasik J and Sillard R (1995) Regulation of adenylate cyclase by galanin, neuropeptide Y, secretin and vasoactive intestinal polypeptide in rat frontal cortex, hippocampus and hypothalamus. Neuropeptides 28:21-28.
12. Lundell I, Statnick MA, Johnson D, Schober DA, Starback P, Gehlert DR and Larhammar D (1996) The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous human receptor. Proc Natl Acad Sci USA 93:5111-5115.
13. McLean LR, Baron BM, Buck SH and Krstenansky JL (1990) Lipid and membrane interactions of neuropeptide Y. Biochim Biophys Acta 1024:1-4.
14. Michel MC (1991) Receptors for neuropeptide Y: Multiple subtypes and multiple second messengers. Trends Pharmacol Sci 12:389-394.
15. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T and Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143-150.
16. Mousli M, Bueb J-L, Bronner C, Rouot B and Landry Y (1990) G protein activation: A receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 11:358-362.
17. Mousli M, Trifilieff A, Pelton JT, Gies J-P and Landry Y (1995) Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur J Pharmacol 289:125-133.
18. Ny L and Grundemar L (1997) Inhibition of stimulated cyclic AMP production by multiple neuropeptide Y receptors in the rat brainstem. Neurosci Lett 221:113-116.
19. Odagaki Y and Fuxe K (1995a) Functional coupling of dopamine D2 and muscarinic cholinergic receptors to their respective G proteins assessed by agonist-induced activation of high-affinity GTPase activity in rat striatal membranes. Biochem Pharmacol 50:325-335.
20. Odagaki Y and Fuxe K (1995b) Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes. J Pharmacol Exp Ther 274:337-344.
21. Odagaki Y and Fuxe K (1997) Agonist-induced high-affinity GTP hydrolysis as an index of receptor-mediated G protein activation in mammalian brain membranes, in Methods in Molecular Biology, vol 83: Receptor Signal Transduction Protocols (Challis RAJ ed) pp 133-141, Humana Press, Totowa.
22. Odagaki Y, Nishi N and Koyama T (1997) Effects of the wasp venom peptide, mastoparau, on GTP hydrolysis in rat brain membranes. Br J Pharmacol 121: 1406-1412.
23. Odagaki Y, Nishi N and Koyama T (1998a) Receptor-mediated and receptor-independent activation of G-proteins in rat brain membranes. Life Sci 62:1537-1541.
24. Odagaki Y, Nishi N, Ozawa H, Saito T, Takahata N, Riederer P and Koyama T (1998b) Measurement of receptor-mediated functional activation of G proteins in postmortem human brain membranes. Brain Res 789:84-91.
25. Petrenko S, Olianas MC, Onali P and Cessa GL (1987) Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus. Eur J Pharmacol 136:425-428.
26. 35S] binding at activated NPY receptor subtypes in adult rat brain. Mol Brain Res 58:74-82.
27. 1 receptor antagonist: BIBP3226. Eur J Pharmacol 271:R11-R13.
28. Shen GH, Grundemar L, Zukowska-Grojec Z, Hakanson R and Wahlestedt C (1991) C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents. Eur J Pharmacol 204:249-256.
29. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
30. Tatemoto K (1982) Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485-5489.
31. Tatemoto K, Carlquist M and Mutt V (1982) Neuropeptide Y: A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (Lond) 296:659-660.
32. Trinh T, Dumont Y and Quirion R (1996) High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. Eur J Pharmacol 318:R1-R3.
33. Wahlestedt C, Grundemar L, Hakanson R, Heilig M, Shen GH, Zukowska-Grojec Z and Reis DJ (1990) Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 611:7-26.
34. Wahlestedt C and Reis DJ (1993) Neuropeptide Y-related peptides and their receptors: Are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 32:309-352.
35. Westlind-Danielsson A, Andell S, Abens J and Bartfai T (1988) Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum. Acta Physiol Scand 132:425-430.
36. Westlind-Danielsson A, Unden A, Abens J, Andell S and Bartfai T (1987) Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex. Neurosci Lett 74:237-242.
37. 2-type receptors in rat brain. Brain Res 539:196-202.
38. 2-adrenoceptors in selective rat brain regions. Peptides 12:71-75.